Rowland Carmichael Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-19,974
Closed -$850K 295
2017
Q1
$850K Sell
19,974
-10,707
-35% -$437K 0.52% 56
2016
Q4
$1.23M Hold
30,681
0.73% 26
2016
Q3
$1.19M Hold
30,681
0.76% 28
2016
Q2
$1.06M Buy
30,681
+20,105
+190% +$696K 0.67% 39
2016
Q1
$365K Buy
+10,576
New +$369K 0.34% 100

Other funds holding HOLX

Rowland Carmichael Advisors's HOLX Position: Q2 2017 in Review

Rowland Carmichael Advisors sold out of Hologic (HOLX) in Q2 2017, closing a stake of 19,974 shares — an estimated $850K sold.

Rowland Carmichael Advisors first reported a position in HOLX in Q1 2016 and held it in 5 quarters. The position peaked at $1.23M in Q4 2016. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Rowland Carmichael Advisors reported no remaining Hologic position as of Q2 2017 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 19,974 Hologic shares in Q2 2017, an estimated $850K.
  • Rowland Carmichael Advisors first reported a position in Hologic in Q1 2016 and held it in 5 quarters.
  • Rowland Carmichael Advisors's Hologic position peaked at $1.23M in Q4 2016.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Rowland Carmichael Advisors's 13F filing for Q2 2017, filed 10 Feb 2020.